National Research Corporation Announces Fourth Quarter Results
Portfolio Pulse from
National Research Corporation (NRC Health) reported its Q4 2024 financial results, showing a decrease in revenue and earnings per share compared to Q4 2023. Revenue was $36.9 million, down from $38.0 million, and EPS was $0.28, down from $0.36.
January 27, 2025 | 10:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NRC Health's Q4 2024 results show a decline in both revenue and earnings per share compared to the previous year, indicating potential challenges in maintaining growth.
The decrease in revenue from $38.0 million to $36.9 million and the drop in EPS from $0.36 to $0.28 suggest financial challenges, which could negatively impact investor sentiment and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100